bisoprolol has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bax, JJ; Boersma, E; Kertai, MD; Klein, J; Lameris, TW; Poldermans, D; Schouten, O; Simoons, ML; van de Ven, LL; van Urk, H; Vermeulen, M; Visser, L | 1 |
Bax, JJ; Boersma, E; Dunkelgrun, M; Koopman-van Gemert, AW; Poldermans, D; Schouten, O; Thomson, IR; van Poorten, F | 1 |
Furuichi, Y; Sakamoto, A | 1 |
2 review(s) available for bisoprolol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Cohort Studies; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heart Arrest; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Indoles; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Risk Factors; Treatment Outcome | 2009 |
[Perioperative cardiovascular evaluation and management for noncardiac surgery].
Topics: Adrenergic beta-Antagonists; Anesthesia; Atenolol; Bisoprolol; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Intraoperative Complications; Metoprolol; Monitoring, Intraoperative; Morpholines; Myocardial Infarction; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Urea | 2014 |
1 trial(s) available for bisoprolol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Cohort Studies; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heart Arrest; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Indoles; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Risk Factors; Treatment Outcome | 2009 |
1 other study(ies) available for bisoprolol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Cardiovascular Diseases; Drug Therapy, Combination; Elective Surgical Procedures; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Indoles; Intraoperative Complications; Myocardial Infarction; Perioperative Care; Postoperative Complications; Premedication; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design; Risk Assessment | 2004 |